UK markets open in 11 minutes

Bone Biologics Corporation (BBLG)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5400+0.0500 (+3.36%)
At close: 04:00PM EDT
1.4900 -0.05 (-3.25%)
After hours: 04:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.4900
Open1.6000
Bid0.0000 x 1000
Ask0.0000 x 1100
Day's range1.4500 - 1.6000
52-week range1.0800 - 7.1220
Volume14,236
Avg. volume20,024
Market cap15.94M
Beta (5Y monthly)0.35
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

    BURLINGTON, Mass., March 23, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, has been invited to present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30, 2022. A pre-recorded presentation will be available for 72 hours beginning Monday, March 28th at 9:00 a.m. Eastern time. Interested p

  • Business Wire

    Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

    BURLINGTON, Mass., March 07, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with MTF Biologics for demineralized bone matrix (DBM). MTF Biologics is a global nonprofit organization that provides one of the orthopedic industry’s largest portfolios of allograft tissue.

  • Business Wire

    Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

    BURLINGTON, Mass., January 05, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 – 13, 2022. A pre-recorded presentation will be available beginning Monday, January 10 at 7:00 a.m. Eastern time. Interested parties may access a webcast of the presentation on